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Follicular dendritic cells (FDC) show homo- and heterocellular metabolic coupling through connexin 43 (Cx43) gap junctions and
support B cell selection and maturation in germinal centers. In follicular lymphomas B cells escape apoptosis while FDC develop
abnormally. Here we tested Cx43 channels in reactive FDC development and follicular lymphomas. In culture, the treatment
of FDC-B cell clusters (resembling to “ex vivo” germinal centers) with Gap27 peptide, mimicking the 2nd extracellular loop of
Cx43 protein, significantly impaired FDC-B cell cluster formation and cell survival. In untreated cultures of intact clusters, cell
proliferation showed a moderate reduction. In tissues, Cx43 protein levels run parallel with the density of FDC both in reactive
germinal centers and in malformed follicles of follicular lymphomas and showed strong upregulation in newly generated and/or
degrading bi-/multinuclear FDC of rudimentary processes. However, the inverse correlation between Cx43 expression and B
cell proliferation seen in reactive germinal centers was not detected in follicular lymphomas. Furthermore, Cx43 levels were not
associatedwith either lymphoma grade or bonemarrow involvement. Our results suggest that Cx43 channels are critical in FDC and
“ex vivo” germinal center development and in the persistence of FDC in follicular lymphomas but do not affect tumor progression.
1. Introduction
Follicular dendritic cell (FDC) meshwork serves as a scaf-
folding and antigen trap in germinal centers for boosting the
generation of high affinity antibodies and B cell memory [1].
High affinity B cell clones are selected and rescued for survival
through their binding antigens presented by FDC [2]. We
earlier showed that, besides cell-cell adhesion and secreted
cytokines, FDC can also mediate homo- and heterocellular
direct interactions through cell membrane channels formed
by connexin 43 (Cx43) protein [3]. Gap junction direct cell-
cell communication couples members of the FDCmeshwork
for a functional syncytium, which can also be directly linked
through Cx43 channels to germinal center B cells [3, 4].
In this study, we tested FDC-B cell cultures and follicular
lymphomas (FL) of atypical FDC to see how critical Cx43
channels are in FDC development and maintenance and if
Cx43 levels influence FL progression.
Gap junction channels are formed by aligning of con-
nexin hemichannels of adjacent cell membranes [5]. The
hemichannels, which may also function independently as a
secretory pathway for releasingATP, aremade of six tetraspan
transmembrane connexin molecules of 21 isotypes in human
[6, 7]. Gap junctions allow the rapid exchange of <1.8 kDa
molecules including morphogenes, second messengers (e.g.,
Ca2+, IP
3
, and c-AMP), metabolites (e.g., nucleic acids and
amino acids), and linear antigenic peptides of <1.2–1.8 kDa
between cells at selective permeability depending on the
isotype(s) involved [8]. Connexins and their channels can
mediate signals concernedwith cell differentiation, apoptosis,
cell cycle control, and the formation of functional compart-
ments within tissues [9–11]. Connexins are expressed in most
immune cells and have been linked to the regulation of
early hematopoiesis and immunoglobulin production and to
the promotion of cellular immune response through antigen
cross-presentation [5, 12].
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FDC is also an important component of FL, an indo-
lent neoplasia of follicular B cells, which frequently show
t(14;18)(q32;q21) chromosomal translocation resulting in the
overexpression of the antiapoptotic Bcl-2 protein [13, 14].
FL tumor cells, characterized by CD10, bcl-2 and bcl-6
immunoreactions, are arranged in follicular structures of
irregular sizes that may resemble reactive follicles but with
a lost polarization [15, 16]. Follicular areas can be highlighted
by CD21, CD23, and CD35 positive distorted FDCmeshwork
which shows alternating focal hyperplasia and fragmentation
[17]. Diminishing and lost follicular pattern in grade 3 FL
correlates with the progression of FL into diffuse large B
cell lymphoma (DLBCL) of poor outcome in 25–35% of the
patients [14]. Bone marrow involvement of FL affecting 40–
70% of the cases, where FDC and follicular structures may
also form, indicates an adverse FL prognosis too [18–20]. On
the other hand, stromal cells including FDC can support lym-
phoma B-cell survival and may contribute to the resistance
both to chemotherapy and biological (trastuzumab) therapy
targeting CD20 protein in tumor cells with a humanized
monoclonal antibody [21–24].
In cultured low density cell fractions of reactive human
tonsils, FDC-B cell clusters can form resembling to ex
vivo germinal centers [4, 25]. In this study, Cx43 docking
and channel functions were perturbed by treating of these
cultures with Gap27 connexin mimetic peptide which corre-
sponds to the second extracellular loop (E2) of Cx43 protein
[26]. Gap27 peptide significantly impaired the formation of
FDC-B cell clusters and cell survival. Cx43 expression showed
strong statistical correlation with the FDCmeshwork both in
reactive germinal centers and in FL, and it was upregulated
in bi- or multinuclear FDC of underdeveloped processes.
However, Cx43 levels had no significant association with
either neoplastic B cell proliferation, tumor grade, or bone
marrow involvement in FL. Our results suggest that Cx43
channels are critical in FDC and in “ex vivo” germinal center
development and in the persistence of FDC in FL butmay not
play a significant role in FL progression. Since FDCs nurse
FL B cells, inhibition of Cx43 in FL would likely to hinder
FDC growth and eliminate its trophic factors for tumor
cell survival and support chemotherapy and/or biological
therapy.
2. Materials and Methods
2.1. FDC-B Lymphocyte Cultures. Low density cell fractions
of human tonsils, known to be enriched in activated germinal
center B lymphocytes and FDC, were isolated with the
consent of the patients as described before [4, 27]. All
reagents specified were from Sigma-Aldrich (St Louis, MO).
Briefly, surgically excised tonsils were minced and then
digested twice for 30min each in 200U/mL collagenase IV
(C5138) and 10U/mL DNase I (D4263) containing 90 𝜇g/mL
gentamycin (G1272) in 30mL Iscove’s modified Dulbecco’s
medium (IMDM; I3390), at 37∘C. The supernatants kept
on ice were centrifuged at 600 g for 10min, resuspended in
IMDM, and layered (at 1×g) on discontinuous BSA gradients
consisting of layers of 1.5%, 2.5%, and 5% BSA (A9706) in
Hanks’ balanced salt solution (H6648). Then the low density
cells between the interfaces of 2.5% and 5% BSA were layered
on Percoll gradients (P4937) and centrifuged at 1200×g at
4∘C for 20min to allow collection of <1060mg/mL density
cells. Isolated cells were either cytospinned or cultured on 24×
24mm microscope coverslips (2–4 × l05 cells) for 2–24 h in
IMDM containing 0.1% gentamycin and 10% fetal calf serum
under 5% O
2
, 5% CO
2
, and 90% N
2
. For immunostaining,
cells were fixed in acetone for 10min and dried at room
temperature for 30min.
2.2. Blocking of Cx43 Gap Junctions with Gap27 E2 Domain
Mimetic Peptide. After preliminary testing, Gap27 connexin
mimetic peptide (G1794; Sigma-Aldrich) mimicking the
aa204–214 sequence on the 2nd extracellular loop of Cx43
(SRPTEKTIFII) was added to the culture media in 200𝜇M
final concentration onto each coverslip cultures contain-
ing 2–4 × 105 cells isolated from reactive human tonsils.
Cell phenotype, all cell numbers, and average cell num-
bers within clusters were monitored and compared between
Gap27 treated cultures and cultures treated with either
100 𝜇g BSA (untreated) or a scrambled peptide sequence
(TFEPDRISITK) at 2 , 4, 6, 12, 16, and 24 h in at least 3
parallel coverslip cultures each time by counting 300 cells
on each coverslip. Coverslip cultures were either immunos-
tained (see below) or analyzed after nuclear staining with 7-
aminoactinomycin D (7-AAD; 1 : 1000; Invitrogen, Carlsbad,
CA) for 1min, postfixed in 4% neutral buffered formaldehyde
for 10min, and mounted using Faramount (Dako, Glostrup,
Denmark). Samples were tested with Leica TCS4D confocal
laser scanning microscope (Leica Lasertechnique, Heidel-
berg, Germany) using single and multichannel fluorescence
combined with differential interference (Nomarski) optics.
2.3. Biopsy Samples and Tissue Microarray. Formaldehyde-
fixed, paraffin embedded lymphnode biopsies of 35 untreated
FLpatients and the corresponding bonemarrow core biopsies
from 20 patients were selected for this study from the
archives of the 1st Department of Pathology and Experimen-
tal Cancer Research (Budapest). The diagnoses were based
on standard criteria using the classification of the World
Health Organization (WHO) by considering histopathology,
immunophenotype, and molecular features [14]. Clinico-
pathological data of the studied patients are summarized in
Table 1. Bone marrow sampling took place within 2 weeks
of the primary diagnosis of FL. Archived, reactive lymph
node samples from 3 patients were used as normal controls.
Representative areas were selected from each paraffin block
based on routine hematoxylin and eosin staining and at least
duplicate cores of 2mm diameter were collected into tissue
microarray (TMA) blocks using the computer-assisted TMA
Master (3DHISTECH Ltd, Budapest, Hungary) [28]. The use
of all human tissues including native tonsils for research
purposes in this study has been approved by the Ethical Board
of Semmelweis University (TUKEB 7/2006).
2.4. Immunohistochemistry. Four 𝜇m thick TMA sections
were cut, mounted on charged adhesive slides (Super-
Frost Ultra Plus, Braunschweig, Germany), and immunos-
tained following routine dewaxing. For heat induced epitope
Journal of Immunology Research 3
Table 1: Clinicopathological data of follicular lymphomas studied.
Bone marrow involvement Total
Presence Absence
Sex Female 12 (60%) 9 (60%) 21 (60%)
Male 8 (40%) 6 (40%) 14 (40%)
Age at
diagnosis
Median 48.65 49.67 49.16
Range 26–82 33–74 26–82
Grade
1 1 (5%) 3 (20%) 5 (12.5%)
2 16 (80%) 6 (40%) 24 (60%)
3 3 (15%) 6 (40%) 11 (27.5%)
Histologic
pattern
Follicular 20(100%) 12 (85%) 32 (92.5%)
Diffuse 0 (0%) 3 (15%) 3 (7.5%)
FLIPI
Low 2 9 11
Intermediate 12 5 17
High 6 1 7
Treatment
response
Complete
remission 5 13 18
Partial
remission 13 2 15
No response 2 0 2
retrieval, in an electric cooker at ∼105∘C for 28min (Awair,
Biofa Kft, Veszprem, Hungary), a mixture of 0.1M Tris-base
and 0.01M EDTA, pH 9.0, was used, except for detecting
CD21 where a pH 6.1 target retrieval solution (TRS, Dako)
was applied. After blocking the endogenous peroxidases
in 1% H
2
O
2
for 20min the sections were incubated with
primary antibodies (all from Dako, if not otherwise noted)
including mouse monoclonal anti-CD10 (clone: 56C6, 1 : 20),
anti-CD21 (clone: 1F8, 1 : 20), anti-CD23 (clone: 1B12, 1 : 10,
Leica-NovoCastra, Newcastle upon Tyne, UK), anti-low-
affinity nerve growth factor receptor (LNGFR, clone: 7F10,
1 : 300; AbCam, Cambridge, MA), and Ki67 (clone: Mib1,
1 : 50) IgG at room temperature, for 60 min. Tissue-bond
antibodies were detected using the NovoLink (RE7140-CE;
Leica) polymer peroxidase system by incubating the slides
with the postprimary reagent for 30min and then with the
peroxidase polymer conjugate for 40min. Peroxidase activity
was revealed with the diaminobenzidine-H
2
O
2
chromogen-
substrate system for 5–8min. After each incubation step the
slides were washed in 0.1M Tris-buffered saline pH 7.4 (TBS)
including 0.05% Tween 20 for 3 × 3min and, finally, were
counterstained with hematoxylin.
2.5. Immunofluorescence and Double Staining. After fixation
in methanol-acetone (1 : 1) for 10min, FDC-B cell cultures
grown on microscope coverslips were also tested with
immunofluorescence using rabbit anti-Cx43 (code: #3512,
1 : 200; Cell Signaling, Beverly, MA) and mouse anti-Ki67
(clone: Mib1, 1 : 100) IgG or combining either monoclonal
mouse anti-Cx43 (Clone: CX-1B1, 1 : 100, Life Tech., Grand
Island, NY) with rabbit anti-human IgM (A0425, 1 : 300),
or IgG (A0423, 1 : 500) antibodies or rabbit anti-Cx43
(code: #3512, 1 : 200) with mouse anti-CD35 (clone: Ber-
Mac-DRC, 1 : 50) antibodies for double labeling. Mouse and
rabbit antibodies were detected with either Alexa488 (green)
or Alexa546 (orange-red) labeled anti-mouse or anti-rabbit
IgG, diluted in 1 : 200 (all from Invitrogen-Molecular Probes,
Carlsbad, CA). Immunofluorescence was also used on FL
TMA paraffin sections, following the same section pretreat-
ment described above. Sections were incubated with rabbit
anti-Cx43 (#3512, 1 : 100) or monoclonal mouse anti-Cx43
(clone: CX-1B1, 1 : 100) IgG either alone or in relevant com-
binations (mouse and rabbit) with rabbit anti-desmoplakin
IgG (Dp12, 1 : 200; generous gift from A.I. Magee, National
Institute for Medical Research, Mill Hill, London, UK),
monoclonal mouse anti-CD4 (clone: 4B12, 1 : 20), anti-CD10
(clone: 56C6, 1 : 30), anti-CD21 (clone: 1F8, 1 : 20), or Ki67
(clone: Mib1, 1 : 100) IgG at room temperature, overnight
using the same immunofluorescence detection reagents as for
cultured cells. Cell nuclei were stained with either Hoescht
(blue) or 7-aminoactinomycin (red). The slides were finally
mounted with a gelatin-based medium Faramount.
2.6. Scoring and Automated Image Analysis of Signals. In
FDC-B cell cultures, the number of cells within clusters, the
number of all cells (indicating cell survival), andKi67 positive
cells (and proliferating cell fractions) was determined in 3–5
representative, calibrated ×40 magnified images of 3 parallel
samples at each time point. For all cells andKi67 positive cells
the findings were extrapolated for 1mm2. Immunostained
TMA slides were subjected to whole slide digitalization at
either bright-field or fluorescence using Pannoramic Scanner
(3DHISTECH) equippedwith a high resolution×20 objective
(NA = 0.83; Carl Zeiss, Jena, Germany). Representative CD10
positive FL areas were scored independently by two experts
(HR and TK) for Cx43, CD21, CD23, and Ki67 by assessing
the proportion (%) of tumor cells positive for the given
biomarker using a 4-tier scale where score 0 represented
<10%; score 1 represented 10–25%; score 2 represented 26–
50%; and score 3 > 50% of Cx43 positive area fraction of the
tumors, and the results were consolidated based on agree-
ment. For further analysis Cx43 and Ki67 immunopositive
area fractions in % were determined in CD10+/CD21+/high
and CD10+/CD21−/low areas in reactive follicles, FL lymph
nodes, and in bonemarrow involvement of FL using standard
thresholds in the HistoQuant software (3DHISTECH).
2.7. Statistics. Statistical analysis was performed using the
SPSS 15.0 software package (IBM-SPSS Inc., Chicago, IL).
Spearman’s rank test was used for revealing correlations
between biomarker levels. Statistical significance between
rank variable scores of CD21 (FDC) and Cx43 reactions in
CD10 positive FL areas and bone marrow involvement of FL
was analyzed using the Fisher exact test after dichotomization
of scoring data at the most reproducible threshold 0-1 (low)
versus scores 2-3 (high). The Wilcoxon paired nonpara-
metric test was used to compare variables in FDC-B cell
culture experiments and for testing Cx43 and Ki67 protein
levels in CD10+/CD21+(high) and CD10+/CD21−(low) FL
areas. 𝑃 values of <0.05 were considered as statistically
significant.
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Figure 1: Connexin 43 expression in secondary lymphoid follicles of reactive human tonsils. Cx43 immunoreaction (red) is accumulated
mainly in the light zone localizing less Ki67 positive lymphocytes ((a), green) and more CD21 positive FDC processes ((b), green) than the
dark zone (circled areas) of germinal center in consecutive sections. Cx43 (green) colocalizes with desmoplakin (red) produced by FDC ((c);
arrowheads). Cx43 plaques (green) are also closely associated with B cells ((d); arrowheads) and rarely with CD4 positive T cells ((e); Cx43:
red, CD4: green, arrowhead) in the germinal center. Immunofluorescence, nuclear staining in (a), (b), and (e) with Hoescht (blue) and in (d)
with 7-aminoactinomycin D (red). LZ: light zone and MZ: mantle zone. Scale bar on (a) shows 30 𝜇m on (a) and (b); 15 𝜇m on (c) and (e);
and 7𝜇m on (d).
3. Results
3.1. Cx43 Expression in Reactive Lymphoid Follicles. In reac-
tive lymphoid follicles particulate Cx43 immunoreaction
was primarily associated to the FDC meshwork identified
with CD21 (C3d, complement receptor) immunostaining
(Figures 1(a)-1(b)). Significantly higher Cx43 levels were
seen in the light zone where FDC was more developed and
proliferating B cells were fewer than in the dark zone (see
also Figures 4(l) and 4(m)). Cx43 reaction colocalized with
CD21 and the desmosomal adhesion protein desmoplakin,
both produced by FDC (Figure 1(c)). It was also detected in B
cells (Figure 1(d)) and less frequently in CD4 positive T cells
(Figure 1(e)) within germinal centers.
3.2. Blocking of Cx43 in FDC-B Cell Cultures, Ex Vivo Ger-
minal Centers. Isolated low density tonsillar cells enriched
in activated B lymphocytes and FDC formed clusters in 2–
24 h cultures, which mimicked developing germinal centers
ex vivo including gradually growing numbers of B cells
enveloped by protruding sheets of a few FDC. The main
features of this process and the results of treating these
cultures with Gap27 peptide of identical sequence with the
2nd extracellular domain of Cx43 protein are summarized in
Figure 2. Freshly isolated round cells expressing IgM, IgG, or
rarely IgD were decorated with a few Cx43 plaques in their
membranes and were accompanied by a few CD35 positive
presumedFDC (Figure 2(a)). RareCD4+ T lymphocyteswere
also seen but without clear Cx43 positivity. In untreated 2 h
cultures, FDC processes projecting towards and embracing
B cells were densely decorated with Cx43 plaques. By 4 h,
clusters made up of 8–10 cells were formed where Cx43 in
B cell borders colocalized with the CD35 reaction of FDC
(Figure 2(b)). As estimated with double labelling, each FDC
interacted with 3–5 B lymphocytes within cell clusters. From
6 h on, gradually increasing numbers of cells were involved in
clusters reaching >50 cells/cluster by 16 h. The average num-
ber of cells involved in clusters between 2–16 h was signifi-
cantly reduced and FDCprocesseswere underdeveloped after
Gap27 treatment compared to both the untreated and the
indifferent (scrambled) peptide treated cultures (Figure 2(c)).
Furthermore, in Gap27 treated cultures, elevated numbers
of damaged cells showing vacuolated cytoplasm and nuclear
shrinkage suggestive of programmed cells death were seen.
There was a significant decrease in the absolute cell
numbers in the Gap27 treated compared to the untreated
cultures (𝑃 < 0.05) at 6 h, 10 h, and 16 h (Figure 3). Though
the absolute number of Ki67 positive cells did not differ
much, proliferating cell fractions showed a nonsignificant
trend of reduction in untreated compared to Gap27 treated
cultures, except at 2 h.
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Figure 2: Treatment of low density cell fractions of reactive human tonsils in culture using 200 𝜇MGap27 connexin mimetic peptide. (a) At
the start (0 h) round cells are dispersed, some of them coexpressing Cx43 and either IgG or IgM (arrows). In control (untreated) cultures (1st
row) at 2 h, FDC processes decorated with Cx43 (arrows) enmesh round B cells. By 6 h clusters are formed of 10–15 FDC and B cells which
grow up to ∼50 cells by 16 h, with Cx43 plaques detected at the cell borders (arrows). In Gap27 treated cultures (2nd row) the cluster formation
is seriously compromised resulting in cells of vacuolated cytoplasm (arrow) and shrunken nuclei. (b) A “healthy” FDC-B cell cluster of ∼8–
10 cells (some are encircled) with Cx43 particles (red) colocalizing in B cell membranes (yellow, arrows) with sheets of CD35 positive FDC
(green), which envelop them. Immunofluorescence single and double labeling and Nomarski differential interference combined with nuclear
staining using either 7-aminoactinomycin D ((a), red) or Hoescht ((b), blue). (c) Graph showing significantly (∗𝑃 < 0.05; ∗∗𝑃 < 0.005)
reduced cell numbers within clusters after Gap27 treatment compared either to untreated or scrambled-probe treated cultures. Results in
graphs show the mean and standard deviation of at least three independent experiments. Scale bar shows 50 𝜇m, except in the untreated
Cx43 labeled cultures (upper row) where it is 25 𝜇m. In the left row middle panels it equals 15 𝜇m and 10 𝜇m in the bottom panel.
3.3. Cx43 Expression in Follicular Lymphomas. CD10 positive
FL follicles lost polarization compared to reactive germinal
centers and frequently enclosed a fragmented FDC mesh-
work detected with CD21 immunoreaction (Figures 4(a)-
4(b)). Similar to that in reactive follicles, Cx43 expression
was significantly associated with the FDC meshwork (Fig-
ures 4(c)-4(d)), while Cx43 levels were very low in CD10
positive but CD21 negative/low tumor areas. Cx43 protein
was highly upregulated in bi- or multinuclear FDCs with
rudimentary processes and was partly colocalized with CD10
protein on FL B cells. In tumor regions without obvious
vessels, reactive centroblasts, or extracellular matrix, cell
proliferation was not significantly different between areas
of compact or fragmented CD21/Cx43 double positive FDC
(Figures 4(e)-4(f)). In bonemarrow FL infiltrates, the highest
Cx43 levels were detected in CD21/NGFR positive follicles
(Figures 4(g)-4(h)), where Cx43 levels were usually lower and
FDC was more fragmented (Figure 4(i)) than in lymph node
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Figure 3: Testing of cell proliferation (gray columns) and prolif-
erating cell fractions (numbers in gray columns in %) using Ki67
immunocytochemistry and absolute cell numbers (gray + white
columns) indicating cell survival, in FDC-B cell cultures. Absolute
cell numbers are significantly decreased (∗𝑃 < 0.05) 6 h, 10 h, and
16 h afterGap27 treatment compared to the untreated cultures (Unt).
Proliferating cell fractions show a nonsignificant trend of reduction
at these time points (𝑝
6 h = 0.423; 𝑝10 h = 0.186; 𝑝16 h = 0.067) in
the control cultures. Results in graphs show the mean and standard
deviation of at least three independent experiments.
FL follicles. Furthermore, Cx43 levels were higher in FDC-
free diffuse bone marrow FL infiltrates than either in the
preexisting bone marrow (Figure 4(j)) or in the diffuse FDC-
free FL areas in lymph nodes. On the contrary, proliferating
cell fractions were significantly higher in the preexisting
marrow than in bone marrow FL infiltrates. Both FDC and
stromal cell processes were positive for NGFR and occa-
sionally showed continuity with each other in FL infiltrates
at both localizations. Few Cx43 signals were also seen in
NGFR positive stromal cell processes. Graphs summarize the
significant association between CD21 and Cx43 levels in FL
samples (Figure 4(k)) and the correlations of Cx43 or Ki67
levels with CD10+/CD21+(high) and CD10+/CD21−(low) FL
areas (Figures 4(l)-4(m)). Spearman rank correlationwas also
highly significant between Cx43 and CD21 expression (rho
= 0.981, 𝑃 < 0.001), supporting the colocalization of these
proteins. This test showed only a weak negative trend either
between Cx43 and Ki67 (rho = −0.154) or between CD21 and
Ki67 (rho = −0.128) expression.
In lymph node FL, there was no significant correlation
between Cx43 expression and bone marrow involvement or
tumor grade (Table 2) and between the proportion of FDC,
detected using CD21 or CD23 immunoreactions, and tumor
grade (𝑝CD21 = 0.449; and 𝑝CD23 = 0.112).
4. Discussion
Using cultured FDC-B cell clusters, we earlier revealed that
Cx43 gap junctions functionally couple cells of the FDC
meshwork and FDC to germinal center B cells [4]. Here we
show in the same model that interfering with Cx43 docking
and channel functions, by using Gap27 connexin mimetic
Table 2: Connexin 43 protein expression in relation to bonemarrow
(BM) involvement and grade of follicular lymphomas.
Cases
Connexin 43 immunoscore
Sum
Significance
Low (0-1) High(2-3) 𝑃
BM
involvement 5 13 18
No
significance
(0.699)No BMinvolvement 3 12 15
Grade (low:
I-II) 5 19 24
No
significance
(0.651)Grade (high:III) 3 6 9
peptide, can significantly impair the development of FDC-
B cell clusters and cell survival. In tissues, Cx43 protein
expression runs parallel to the density of FDCboth in reactive
germinal centers and in disorganized FL follicles. It is highly
upregulated in large FDC bodies of rudimentary processes,
consistent with either newly developing or degrading FDC.
In reactive germinal centers, local Cx43 levels show an
inverse correlation with B cell proliferation, which is lost in
FL. Still Cx43 expression in FL lymph nodes is not linked
statistically to either FL grade or bone marrow involvement.
These data suggest that Cx43 protein and its channels are
important in FDCmeshwork and in “ex vivo” germinal center
development and in the persistence of FDC in FL but do not
influence significantly FL progression.
Cx43 is the most ancient and prevalent connexin iso-
type, in which involvement in immune functions has been
reported by several groups [12]. In the humoral arm, blocking
of Cx channels was shown to inhibit the immunoglobulin
production of B cells [29]. Cx43 gap junctions were also
implicated in the LFA1-induced Rap1 GTPase activation,
which canmediate CXCL12-directed B cell spreading, migra-
tion, and adhesion [30, 31], which are important in germinal
center reaction. Cx43 channels have also been involved in the
regulation of T cellmaturation and proliferation, in particular
of CD4/Foxp3 double positive regulatory T cells [32–34] and
in the cross-presentation of tumor or viral peptides between
cells [35–37].
The contribution of Cx43 in FDC development and
germinal center reaction was raised earlier by our detection
of progressive accumulation of Cx43 plaques during the
formation of FDC and secondary lymphoid follicles after
repeated antigen challenge in mice [4]. In line with this,
CXCL13, an essential chemokine for FDC and lymph node
generation, can be induced by retinoic acid derived from
vitaminA, a knownpromoter ofCx43 channels [38–40].Here
we provide further evidence on the impact of Cx43 in FDC
growth and potential involvement in germinal center func-
tions. Binding of Gap27 to the 2nd extracellular loop of Cx43
hemichannels is known to result in early channel closure and
diminishing cell coupling [41]. Since FDCs normally grow
long processes and establish strong interactions with each
other, which look abortive and disrupted in Gap27 treated
cultures, FDC adherencemay also be affected through Gap27
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Figure 4: Connexin 43 expression in follicular lymphomas (FL); lymph node localization ((a)–(f)); and bone marrow involvement ((g)–(j)).
Large and irregular follicles dominated by CD10 positive FL B cells (a) and fragmented CD21 positive FDC meshwork (b). Cx43 ((c), red)
reaction colocalizes with that of CD21 ((d), green) in yellow (arrowheads). Insets show a binuclear FDC with highly upregulated Cx43 ((c),
green),and colocalization of Cx43 (red) and CD10 (green) as yellow dots (d). Elevated tumor cell proliferation detected with Ki67 reaction
(green) is seen in FL follicles either with dense FDC and Cx43 reactions ((e); red) or with fragmented FDC and Cx43 staining ((f); circled
area highlights broken or missing FDC). In the bone marrow involvement of FL NGFR (g) and CD21 (inset) positive follicles (arrowhead:
LNGFR positive hyperplastic stromal cells) show themost of Cx43 reaction ((h), red) and proliferating tumor cells (Ki67-green). Strong Cx43
staining ((i), red) is accompanied with only fragmented CD21 reaction (green) in another follicle. Significantly more Cx43 (red) but less Ki67
(green) is detected within a bone marrow FL infiltrate than in the rest of bone marrow (j). Arrowheads in the inset show Cx43 within the
boxed area. Graphs reveal linear correlation between Cx43 and CD21 levels in FL (k) and Cx43 (l) or Ki67 (m) expression in FDC rich and
FDC poor FL areas. Immunoperoxidase ((a), (b), and (g)) and immunofluorescence staining ((c)–(f) and (h)–(j)). Blue nuclear staining using
hematoxylin ((a), (b), and (g)) or Hoescht ((c)–(f) and (h)–(j)). Significance: ∗𝑃 < 0.05 and ∗∗𝑃 < 0.005. Scale bar on (a) shows 150 𝜇m on
(a) and (b); 30 𝜇m on (c) and (d); 120𝜇m on (e), (f), (g), (i), and (j); and 100 𝜇m on (h).
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directly preventing anchorage of the opposing connexin
loops.
In germinal centers, FDC provide a supportive niche
for B cell survival involving direct FDC-B cell interac-
tions including CXCL13/CXCR5, CXCL12/CXCR4, ICAM-
1/LFA-1, and VCAM-/VLA-4 antigen trapped by CD21 and
CD35 complement receptors or by FC𝛾R and FC𝜀R (CD23)
immunoglobulin Fc receptors for reaching out by B cell
receptors as well as by releasing cytokines such as BAFF, IL-
6, and IL-15 (16) [1, 42–45]. In addition, Cx43 channels are
formed by both FDC and B lymphocytes, which permit their
homo- and heterocellular (FDC-B cell) metabolic coupling
[3, 4, 46, 47]. In culture, activated B cells are also prone
to apoptotic cell death without FDC help and/or T cell
interactions [48]. By interferingwith FDCdevelopment using
Gap27 peptide, FDC support of B cell survival is also abused,
resulting in concomitant damage of B cells. Besides reducing
cell numbers within clusters, Gap27 treatment also led to a
significant decrease in the absolute cell numbers, while pro-
liferating cell fractions were moderately elevated compared
to untreated controls. This is consistent with a significantly
reduced cell survival and increased detachment and loss of
damaged cells after Gap27 treatment, while numerous cells
which are dominantly out of clusters can still proliferate. It is
likely that both gap junctions and hemichannels are affected
and both homo- and heterocellular Cx43 channels which are
involved [41]. However, further studies are required to clarify
the mechanisms of action of Gap27 peptide on FDC-B cell
interactions, B cell maturation, and the potential involvement
of hemichannels.
In FL B cells, forced Bcl-2 expression protects tumor cells
from apoptosis, but B cell survival factors released by FDC
and T cells are still important for FL B cells persistence. In
line with this, FL B cells cannot be grown in culture without
factors produced by FDC and CD4+ T helper cells including
CD40L, IL-2, and IL-4 [49–51]. Since Cx43 channels may
support FDC development and survival even in FL, blocking
of Cx43 would most likely impair FDC and its production of
B cell survival factors, which have been implicated in the FDC
mediated therapy resistance of FL B cells [22–24].
TheFDCmeshwork is frequently distorted in FL, showing
local hyperplastic cell bodies with rudimentary processes and
complete loss of FDC in CD10+ diffuse tumor infiltrates [14].
Since normal germinal center structure is based on trophic
and regulatory factors shared between T helper cells, B
cells, and FDC, deformed FDC reflects inappropriate trophic
signaling by malignant B cells [52]. The importance of Cx43
channels in syncytial FDC is reflected by their following of
the pattern and density of FDC detected with CD21 (and
CD23) immunoreactions both in reactive germinal centers
and in FL follicles. In addition, Cx43 protein is particularly
upregulated in bi- or multinuclear FDCs of large cell bodies
but rudimentary processes, which are likely to be either newly
forming or degrading FDC in FL. These findings are in line
with our results in Gap27 treated cultures by both supporting
the role for Cx43 channels in FDC development and survival.
Cx43 channels have been implicated in cell cycle con-
trol and cell differentiation [53]. In reactive germinal cen-
ters the inverse correlation between Cx43 expression and
proliferating B cell fraction suggested Cx43 a role in the
control of B cell proliferation. A similar but nonsignificant
trend was observed in untreated FDC-B cell cultures of intact
cell clusters. Also, in the diffuse bonemarrow infiltrates of FL,
LNGFR positive stromal cell hyperplasia was accompanied
by significantly higher Cx43 expression, lower B cell prolif-
eration, and tumor grade. It is of note, however, that tumor
microenvironment including elevatedCD8+ T cells, forkhead
box protein 3 (FoxP3)+ T cells, and CD68+ macrophages
can also contribute to the downgrading of bone marrow FL
[28]. Nevertheless, Cx43 levels in lymph node FL showed
no significant link with bone marrow involvement or tumor
grade, two known indicators of FL progression.
In conclusion, the exact role of Cx43 channels and cell
coupling in germinal center is still needed to be clarified.
Our earlier study showed that the FDCs are coupled through
Cx43 gap junctions and Cx43 protein is upregulated in FDC
during repeated immune challenge [4]. Here we revealed
that Cx43 channels are crucial for FDC to develop into a
syncytial network which support the survival of FDC-B cell
clusters and for the persistence of FDC in FL but do not
influence significantly the progression of FL. Since both B
cells and T cells can produce Cx43 channels and are in direct
contact with the functionally coupled FDC meshwork, it is
likely that Cx43 channels are involved in the integration of
germinal center functions. Details of the potential metabolic
cooperation between FDC, B cells, and T cells need further
in vivo studies, which have so far been prevented by the
complexity germinal center reaction.
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